Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Diabetic hyperglycaemia causes a variety of pathological changes in small vessels, arteries and peripheral nerves. Vascular endothelial cells are an important target of hyperglycaemic damage, but the mechanisms underlying this damage are not fully understood. Three seemingly independent biochemical pathways are involved in the pathogenesis: glucose-induced activation of protein kinase C isoforms; increased formation of glucose-derived advanced glycation end-products; and increased glucose flux through the aldose reductase pathway. The relevance of each of these pathways is supported by animal studies in which pathway-specific inhibitors prevent various hyperglycaemia-induced abnormalities. Hyperglycaemia increases the production of reactive oxygen species inside cultured bovine aortic endothelial cells. Here we show that this increase in reactive oxygen species is prevented by an inhibitor of electron transport chain complex II, by an uncoupler of oxidative phosphorylation, by uncoupling protein-1 and by manganese superoxide dismutase. Normalizing levels of mitochondrial reactive oxygen species with each of these agents prevents glucose-induced activation of protein kinase C, formation of advanced glycation end-products, sorbitol accumulation and NFkappaB activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prolonged elevated glucose could also signal as a cell stressor through multiple pathways, including hyperosmolarity (McGinn et al., 2003), protein kinase C (PKC) activation (Mandarino, 1992), and oxidative damage (Nishikawa et al., 2000), likely involving pS-STAT3, as well as pY-STAT3.”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Nishikawa et al., 2000
In the citing paper
“Certainly ROSs are known to play a substantive role in both insulin resistance [549-556] and in a variety of diabetic sequelae [95,557-559], and mitochondrial dysfunction may be an early step in this [560].”
In the citing paper
“A variety of studies have shown that iron is involved in these signalling processes [1839,1996,2015,2081-2085], probably again acting upstream of the IKK [557,2083,2086,2087].”
In the citing paper
“The preferential use of the liver to dispose a significant amount of the ingested glucose during first pass, along with a 60–70% hepatic clearance of insulin, protect the peripheral circulation from excessive hyperglycemia/hyperinsulinemia in the postprandial period [35,36,37,38,39,40,41,42,43].”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [36]
In the citing paper
“In this way, it was showed that a diet saturated in fats and carbohydrates can cause several mood-related brain mechanisms damage [305].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [305]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Korshunov, S. S., Skulachev, V. P., & Starkov, A. A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01159-9 · Cited by 1,727 · cited 1×
“There appears to be a threshold value above which superoxide production is markedly increase”
BackgroundProtein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330 · cited 1×
“Three seemingly independent biochemical pathways are involved in the pathogenesis: glucose-induced activation of protein kinase C isoform”
BackgroundDiseases of the mitochondrial DNA
Wallace, D. C. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.005523 · Cited by 1,319 · cited 1×
“Electron flow through the mitochondrial electron transport chain is carried out by four inner-membrane-associated enzyme complexes, with cytochrome c and the mobile carrier ubiquinon”
BackgroundAdvanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Self-citationPark, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104 · cited 1×
“The relevance of each of these pathways is supported by animal studies in which pathway-specific inhibitors prevent various hyperglycaemia-induced abnormalitie”
BackgroundAmelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103 · cited 1×
“The relevance of each of these pathways is supported by animal studies in which pathway-specific inhibitors prevent various hyperglycaemia-induced abnormalitie”
BackgroundTrumpower, B. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38410-8 · Cited by 595
Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13245 · Cited by 564 · cited 1×
“Overexpression of manganese superoxide dismutase (Mn-SOD), the mitochondrial form of this antioxidant enzym”
BackgroundShinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513
Self-citationLee, A. Y., Chung, S. K., & Chung, S. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2780 · Cited by 310 · cited 1×
“; and increased glucose flux through the aldose reductase pathwa”
Background
Research works printed but not linked: 1
- National Diabetes Data Group Diabetes in America 2nd edn (National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, USA, 1994).
Cited by
Items 401–500 of 1,040
Maloney, E., Sweet, I. R., Hockenbery, D. M., Pham, M., Rizzo, N. O., Tateya, S., Handa, P., Schwartz, M. W., & Kim, F. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.188813 · Cited by 229
Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state
van Loon, L. J. C., & Goodpaster, B. H. (2006) · Pflügers Archiv · doi:10.1007/s00424-005-1509-0 · Cited by 232
“In accordance, increased free radical damage to mtDNA has been reported in type 2 diabetes patients [ 59 ].”
BackgroundBrouwers, O., Niessen, P. M., Ferreira, I., Miyata, T., Scheffer, P. G., Teerlink, T., Schrauwen, P., Brownlee, M., Stehouwer, C. D., & Schalkwijk, C. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144097 · Cited by 229
Self-citationIschemia reperfusion injury, ischemic conditioning and diabetes mellitus
Lejay, A., Fang, F., John, R., Van, J. A. D., Barr, M., Thaveau, F., Chakfe, N., Geny, B., & Scholey, J. W. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.020 · Cited by 229
Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications
Sangwung, P., Petersen, K. F., Shulman, G. I., & Knowles, J. W. (2020) · Endocrinology · doi:10.1210/endocr/bqaa017 · Cited by 218
The Keap1-Nrf2 system and diabetes mellitus
Uruno, A., Yagishita, Y., & Yamamoto, M. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.12.012 · Cited by 231
Hydrogen Peroxide as a Paracrine Vascular Mediator: Regulation and Signaling Leading to Dysfunction
Ardanaz, N., & Pagano, P. J. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100302 · Cited by 232
Insulin Treatment Improves the Systemic Inflammatory Reaction to Severe Trauma
Jeschke, M. G., Klein, D., & Herndon, D. N. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000118569.10289.ad · Cited by 230
De M. Bandeira, S., Da Fonseca, L., Da S. Guedes, G., Rabelo, L., Goulart, M., & Vasconcelos, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14023265 · Cited by 224
“Oxidative damage may contribute to the development of complications linked to diabetes [15], being well accepted that RONS production induced by hyperglycemia represents the key event of such complications [17] (Figure 2).”
BackgroundStudies of Rat and Human Retinas Predict a Role for the Polyol Pathway in Human Diabetic Retinopathy
Dagher, Z., Park, Y. S., Asnaghi, V., Hoehn, T., Gerhardinger, C., & Lorenzi, M. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2404 · Cited by 231
“Second, prevention was afforded in the presence of severe hyperglycemia, which would be expected to activate several proposed pathways of tissue damage, including excess superoxide production (38), formation of advanced glycation end products (39), and activation of protein kinase C isoforms (40) along with the polyol…”
BackgroundYamagishi, S.-I., Edelstein, D., Du, X.-L., & Brownlee, M. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1491 · Cited by 225
“We have recently shown that hyperglycemia-induced mitochondrial overproduction of superoxide serves as a causal link between elevated glucose and each of the three major pathways responsible for hyperglycemic vascular damage in endothelial cells (9).”
BackgroundSelf-citationHealth Benefits of Fasting and Caloric Restriction
Golbidi, S., Daiber, A., Korac, B., Li, H., Essop, M. F., & Laher, I. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0951-7 · Cited by 217
Ungvari, Z., Bailey-Downs, L., Gautam, T., Sosnowska, D., Wang, M., Monticone, R. E., Telljohann, R., Pinto, J. T., de Cabo, R., Sonntag, W. E., et al. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr092 · Cited by 226
Advanced glycation end‐products and the kidney
Busch, M., Franke, S., Rüster, C., & Wolf, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02317.x · Cited by 226
The role of advanced glycation in the pathogenesis of diabetic retinopathy
Stitt, A. W. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00035-2 · Cited by 226
Rosca, M. G., Vazquez, E. J., Chen, Q., Kerner, J., Kern, T. S., & Hoppel, C. L. (2012) · Diabetes · doi:10.2337/db11-1437 · Cited by 218
“Increased availability of glucose-generated reducing equivalents in cultured aortic endothelial (18) and retinal (19) cells or defects in the ETC in epineural (20) and cardiac (21) mitochondria increase the electron pressure at specific mitochondrial sites.”
BackgroundReactive oxygen species mediate a cellular ‘memory’ of high glucose stress signalling
Ihnat, M. A., Thorpe, J. E., Kamat, C. D., Szabó, C., Green, D. E., Warnke, L. A., Lacza, Z., Cselenyák, A., Ross, K., Shakir, S., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0684-2 · Cited by 224
“Recently, an excess of reactive oxygen species (ROS) generated in the endothelium and in target organs such as the retina, kidney and heart in response to hyperglycaemia has been shown to form a causative link between high glucose and diabetic complications [4, 5].”
BackgroundImpact of admission hyperglycemia on hospital mortality in various intensive care unit populations*
Whitcomb, B. W., Pradhan, E. K., Pittas, A. G., Roghmann, M.-C., & Perencevich, E. N. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000189741.44071.25 · Cited by 224
Endothelial Dysfunction and Diabetic Cardiomyopathy
Wang, M., Li, Y., Li, S., & Lv, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.851941 · Cited by 207
“Increased O2 - anion acts with hydroxyl radicals and hydrogen peroxide, which may lead to oxidant injury (47).”
BackgroundMakino, A., Scott, B. T., & Dillmann, W. H. (2010) · Diabetologia · doi:10.1007/s00125-010-1770-4 · Cited by 223
“It has been documented that hyperglycaemia induces excess ROS production, including O2 , in many cell types [31–35, 40–43] and local ROS formation is considered to be a major contributing factor to endothelial dysfunction, including endothelial cell apoptosis [42–44], abnormalities in cell cycling [44] and delayed rep…”
Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase
Love, D. C., Kochran, J., Cathey, R. L., Shin, S.-H., & Hanover, J. A. (2003) · Journal of Cell Science · doi:10.1242/jcs.00246 · Cited by 213
“A clear relationship also exists between mitochondrial superoxide overproduction and O-GlcNAc metabolism (Du et al., 2000; Du et al., 2001; Nishikawa et al., 2000).”
BackgroundInfluentialMitochondrial Dynamics in Diabetes
Yoon, Y., Galloway, C. A., Jhun, B. S., & Yu, T. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3286 · Cited by 215
“Brownlee postulated that superoxide anions produced from the mitochondria under hyperglycemic conditions inhibit the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase, diverting glycolytic intermediates into other harmful pathways implicated in the development of diabetic complications (23, 24, 121).”
Hamanishi, T., Furuta, H., Kato, H., Doi, A., Tamai, M., Shimomura, H., Sakagashira, S., Nishi, M., Sasaki, H., Sanke, T., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2455 · Cited by 223
“Hyperglycemia directly produces a reactive oxygen species (such as superoxide anion) via increased production from the mitochondrial electron transport chain (2) and glucose autoxidation (3).”
BackgroundInfluentialRoy Chowdhury, S. K., Smith, D. R., Saleh, A., Schapansky, J., Marquez, A., Gomes, S., Akude, E., Morrow, D., Calcutt, N. A., & Fernyhough, P. (2012) · Brain · doi:10.1093/brain/aws097 · Cited by 210
“Mitochondrial dysfunction has been proposed as a central me- diator of development of many diabetic complications (Nishikawa et al., 2000; reviewed by Sivitz and Yorek, 2010) and there is accumulating evidence that neuronal mitochondria are impaired.”
BackgroundRole of C-Reactive Protein in Diabetic Inflammation
Stanimirovic, J., Radovanovic, J., Banjac, K., Obradovic, M., Essack, M., Zafirovic, S., Gluvic, Z., Gojobori, T., & Isenovic, E. R. (2022) · Mediators of Inflammation · doi:10.1155/2022/3706508 · Cited by 192
Højlund, K., Wrzesinski, K., Larsen, P. M., Fey, S. J., Roepstorff, P., Handberg, A., Dela, F., Vinten, J., McCormack, J. G., Reynet, C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212881200 · Cited by 221
Review article: Platelet abnormalities in diabetes mellitus
Ferreiro, J. L., Gómez-Hospital, J. A., & Angiolillo, D. J. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110383994 · Cited by 216
“An increase in reactive oxygen species in addition to chronic hyperglycaemia enhances production of advanced glycation end products (AGEs).(82) These glycated proteins may contribute to the development of atherosclerotic complications by activation of the receptor for AGEs (RAGE)(83) and by enhancing platelet aggregat…”
BackgroundSuzuki, K., Murtuza, B., Smolenski, R. T., Sammut, I. A., Suzuki, N., Kaneda, Y., & Yacoub, M. H. (2001) · Circulation · doi:10.1161/hc37t1.094524 · Cited by 217
Self-citationRajesh, M., Mukhopadhyay, P., Bátkai, S., Haskó, G., Liaudet, L., Drel, V. R., Obrosova, I. G., & Pacher, P. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00236.2007 · Cited by 209
“Superoxide production plays a significant role in the pathogenesis of the diabetes-associated endothelial dysfunction (5,18,34,47).”
BackgroundRegulation of Endothelial Function by Mitochondrial Reactive Oxygen Species
Widlansky, M. E., & Gutterman, D. D. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3642 · Cited by 214
“Seemingly disparate pathologic stressors, including thrombin activation of the PAR1/2 receptor (9, 33), leptin (177), hyperglycemia (113), angiotensin II (127), and hypoxemia (74, 121) all appear to induce excessive mitochondrial ROS production, leading to subsequent expression of a dysfunctional endothelial phenotype.”
BackgroundInfluentialYamagishi, S.-I., Nakamura, K., Matsui, T., Inagaki, Y., Takenaka, K., Jinnouchi, Y., Yoshida, Y., Matsuura, T., Narama, I., Motomiya, Y., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602110200 · Cited by 217
Self-citationImportance of pericytes and mechanisms of pericyte loss during diabetic retinopathy
Ejaz, S., Chekarova, I., Ejaz, A., Sohail, A., & Lim, C. W. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00795.x · Cited by 206
Paul, S., Ali, A., & Katare, R. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107613 · Cited by 199
Simple Noninvasive Measurement of Skin Autofluorescence
MEERWALDT, R., LINKS, T., GRAAFF, R., THORPE, S. R., BAYNES, J. W., HARTOG, J., GANS, R., & SMIT, A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.036 · Cited by 214
Srinivasan, S., Hatley, M. E., Bolick, D. T., Palmer, L. A., Edelstein, D., Brownlee, M., & Hedrick, C. C. (2004) · Diabetologia · doi:10.1007/s00125-004-1525-1 · Cited by 216
“Furthermore, inhibition or uncoupling of the mitochondrial electron transport chain in ECs prevents the glucose-mediated increase in ROS [9, 10].”
BackgroundSelf-citationPharmacological prevention of diabetic cataract
Kyselova, Z., Stefek, M., & Bauer, V (2004) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(03)00009-6 · Cited by 211
Basta, G., Lazzerini, G., Del Turco, S., Ratto, G. M., Schmidt, A. M., & De Caterina, R. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000167522.48370.5e · Cited by 211
Crabtree, M. J., Smith, C. L., Lam, G., Goligorsky, M. S., & Gross, S. S. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00823.2007 · Cited by 213
MacLellan, J. D., Gerrits, M. F., Gowing, A., Smith, P. J. S., Wheeler, M. B., & Harper, M.-E. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2343 · Cited by 213
“In vivo overexpression of UCP1 completely reverses hyperglycemia-induced mitochondrial ROS overproduction in aortic endothelial cells (46).”
BackgroundRole of Oxidative Stress and Inflammation in Gestational Diabetes Mellitus
Saucedo, R., Ortega-Camarillo, C., Ferreira-Hermosillo, A., Díaz-Velázquez, M. F., Meixueiro-Calderón, C., & Valencia-Ortega, J. (2023) · Antioxidants · doi:10.3390/antiox12101812 · Cited by 179
“…proteins for the formation of advanced glycation products (AGEs), increasing protein kinase C (PKC) and activating the hexosamine pathway that generates uridine diphosphate-N-acetyl glucosamine (UDP-GlcNAc), which has the ability to bind to proteins and regulate their functions [19–21].”
Yamagishi, S.-I., Amano, S., Inagaki, Y., Okamoto, T., Koga, K., Sasaki, N., Yamamoto, H., Takeuchi, M., & Makita, Z. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6312 · Cited by 209
Self-citationMitochondrial Creatine Kinase Activity Prevents Reactive Oxygen Species Generation
Meyer, L. E., Machado, L. B., Santiago, A. P. S. A., da-Silva, W. S., De Felice, F. G., Holub, O., Oliveira, M. F., & Galina, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604123200 · Cited by 209
Chandrasekharan, B., Anitha, M., Blatt, R., Shahnavaz, N., Kooby, D., Staley, C., Mwangi, S., Jones, D. P., Sitaraman, S. V., & Srinivasan, S. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01611.x · Cited by 211
“Experimental evidence supports the notion that oxidative stress is a causal or contributing factor in neurodegenerative disorders (6,7,8,9).”
BackgroundMolecularly engineered graphene surfaces for sensing applications: A review
Liu, J., Liu, Z., Barrow, C. J., & Yang, W. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.07.031 · Cited by 207
Epigenetics: Mechanisms and Implications for Diabetic Complications
Cooper, M. E., & El-Osta, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.223552 · Cited by 213
Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice
Oliveira, W. H., Nunes, A. K., França, M. E. R., Santos, L. A., Lós, D. B., Rocha, S. W., Barbosa, K. P., Rodrigues, G. B., & Peixoto, C. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.013 · Cited by 209
Role of Oxidative Stress in Pancreatic β‐Cell Dysfunction
KAJIMOTO, Y., & KANETO, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1293.017 · Cited by 206
Mechanisms of distal axonal degeneration in peripheral neuropathies
Cashman, C. R., & Höke, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.048 · Cited by 199
Forbes, J. M., Thorpe, S. R., Thallas-Bonke, V., Pete, J., Thomas, M. C., Deemer, E. R., Bassal, S., El-Osta, A., Long, D. M., Panagiotopoulos, S., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010062 · Cited by 210
“BAEC then were randomized to either low or high glucose (30 mmol/L) at 0.5% FBS in the presence and absence of the active metabolite of the ACEi ramipril, ramiprilat (150 mol/L; Aventis, Frankfurt, Germany); the AT1R antagonist valsartan (10 mol/L); or the mitochondrial reactive oxygen species scavenger idebenone (10…”
MethodInfluentialKakimoto, M., Inoguchi, T., Sonta, T., Yu, H. Y., Imamura, M., Etoh, T., Hashimoto, T., & Nawata, H. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1588 · Cited by 206
“Hyperglycemia, a key clinical manifestation of diabetes, is supposed to generate ROS through various mechanisms, such as increased formation of AGEs (2), enhanced polyol pathway (6,7), increased superoxide release from mitochondria (44), and activation of NAD(P)H oxidase (45).”
BackgroundUCP2 and UCP3 in muscle controlling body metabolism
Schrauwen, P., & Hesselink, M. (2002) · Journal of Experimental Biology · doi:10.1242/jeb.205.15.2275 · Cited by 205
Yoh, K., Hirayama, A., Ishizaki, K., Yamada, A., Takeuchi, M., Yamagishi, S., Morito, N., Nakano, T., Ojima, M., Shimohata, H., et al. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01234.x · Cited by 207
“O2i− Genes to Cells (2008) 13, 1159–1170 © 2008 The Authors Journal compilation © 2008 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd. 1160 reported to promote nuclear translocation and activation of NF-κB (Yerneni et al. 1999; Nishikawa et al. 2000).”
BackgroundSelf-citationPannicke, T., Iandiev, I., Wurm, A., Uckermann, O., vom Hagen, F., Reichenbach, A., Wiedemann, P., Hammes, H.-P., & Bringmann, A. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1349 · Cited by 205
Self-citationMitochondrial dysfunction in diabetic cardiomyopathy
Duncan, J. G. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.014 · Cited by 208
“Brownlee and colleagues have generated significant evidence that mitochondrial ROS activate multiple pathways for cellular damage in the setting of hyperglycemia [89-92].”
BackgroundDiabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies
Whitehead, M., Wickremasinghe, S., Osborne, A., Van Wijngaarden, P., & Martin, K. R. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1545836 · Cited by 198
“This has primarily been driven by evidence that all of the pathogenic mechanisms outlined above drive the production of superoxide by the electron transport chain [42,43].”
BackgroundBhutada, P., Mundhada, Y., Bansod, K., Tawari, S., Patil, S., Dixit, P., Umathe, S., & Mundhada, D. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.022 · Cited by 205
Kamiński, M. M., Sauer, S. W., Kamiński, M., Opp, S., Ruppert, T., Grigaravičius, P., Grudnik, P., Gröne, H.-J., Krammer, P. H., & Gülow, K. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.009 · Cited by 199
“Upregulated glucose metabolism under hyperglycemic and hypoxic conditions was also shown to induce mitochondrial ROS release in different cellular systems (Bell et al., 2007; Nishikawa et al., 2000; Wellen and Thompson, 2010).”
BackgroundInfluentialKawamori, D., Kajimoto, Y., Kaneto, H., Umayahara, Y., Fujitani, Y., Miyatsuka, T., Watada, H., Leibiger, I. B., Yamasaki, Y., & Hori, M. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2896 · Cited by 209
Activation of Nrf2 signaling by natural products-can it alleviate diabetes?
Matzinger, M., Fischhuber, K., & Heiss, E. H. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.015 · Cited by 204
Jha, J. C., Ho, F., Dan, C., & Jandeleit-Dahm, K. (2018) · Clinical Science · doi:10.1042/cs20171459 · Cited by 205
Circulating Oxidative Stress Biomarkers in Clinical Studies on Type 2 Diabetes and Its Complications
Bigagli, E., & Lodovici, M. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5953685 · Cited by 195
“Decreased SOD activity has been implicated in the pathogenesis of retinopathy in diabetes, and its overexpression prevented hyperglycaemia-associated production of ROS, activation of PKC, and AGE formation [46, 47].”
Apostolova, N., Iannantuoni, F., Gruevska, A., Muntane, J., Rocha, M., & Victor, V. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101517 · Cited by 197
“tissue, but under hyperglycaemic conditions, glucose can be shunted to other locations, leading to the generation of AGEs or activation of the polyol pathway [63].”
BackgroundPrevention of diabetic nephropathy in mice by a diet low in glycoxidation products
Zheng, F., He, C., Cai, W., Hattori, M., Steffes, M., & Vlassara, H. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.283 · Cited by 206
“Intracellularly, hyperglycemia influences the production of reactive oxygen species (ROS), transcription factor regulatory systems [51,52] and, together with endogenous a,b-dicarbonyl-precursors can disturb homeostasis [31,33,53].”
BackgroundAutophagy and mitophagy in diabetic cardiomyopathy
Kobayashi, S., & Liang, Q. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.020 · Cited by 205
Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification
Schalkwijk, C. G., Stehouwer, C. D. A., & van Hinsbergh, V. W. M. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.488 · Cited by 206
“duction of oxidative stress in the mitochondria [83].”
BackgroundThe Role of Nrf2-Mediated Pathway in Cardiac Remodeling and Heart Failure
Zhou, S., Sun, W., Zhang, Z., & Zheng, Y. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/260429 · Cited by 202
“Extra production of ROS and RNS causes the development of diabetic complications, including cardiomyopathy; on the other hand, antioxidants can prevent or treat diabetic complications [97, 99, 100].”
Kitada, M., Koya, D., Sugimoto, T., Isono, M., Araki, S.-I., Kashiwagi, A., & Haneda, M. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2603 · Cited by 204
“In diabetes, reactive oxygen species (ROS) is thought to be generated through the increased formation of advanced-glycation end products (3), increased polyol pathway (11), mitochondrial dysfunction (12), and protein kinase C (PKC) activation (13).”
BackgroundVial, G., Chauvin, M.-A., Bendridi, N., Durand, A., Meugnier, E., Madec, A.-M., Bernoud-Hubac, N., Pais de Barros, J.-P., Fontaine, É., Acquaviva, C., et al. (2015) · Diabetes · doi:10.2337/db14-1220 · Cited by 193
“In addition, we cannot exclude a role of imeglimin preventing other deleterious effects of oxidative stress, as previously reported (28,29).”
ResultMatsuda, M., & Shimomura, I. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9271-7 · Cited by 196
“FFAs, especially palmitate, can stimulate diacylglycerol synthesis and activate protein kinase C (PKC), which leads to the activation of NADPH oxidase [53].”
BackgroundInfluentialEl-Remessy, A. B., Behzadian, M. A., Abou-Mohamed, G., Franklin, T., Caldwell, R. W., & Caldwell, R. B. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64332-5 · Cited by 203
Role of mitochondrial oxidative stress in hypertension
Dikalov, S. I., & Ungvari, Z. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00089.2013 · Cited by 201
Metformin Decreases Intracellular Production of Reactive Oxygen Species in Aortic Endothelial Cells
Ouslimani, N., Peynet, J., Bonnefont-Rousselot, D., Thérond, P., Legrand, A., & Beaudeux, J.-L. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.029 · Cited by 204
“High blood glucose levels, which occur in vivo during the postprandial state and in nonequilibrated diabetic subjects, stimulate endothelial ROS production through protein kinase C (PKC)-dependent activation of NAD(P)H oxidase in cultured endothelial cells [35], and also by increasing mitochondrial superoxide producti…”
BackgroundThe c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation
Wonsey, D. R., Zeller, K. I., & Dang, C. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102523299 · Cited by 205
Goveia, J., Stapor, P., & Carmeliet, P. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404156 · Cited by 200
“While the precise effects on mitochondrial respiration require further study, hyperglycemia-induced mitochondrial ROS induces DNA breaks and thereby activates polyAPD-ribose polymerase (PARP-1) (Du et al , 2000, 2003; Nishikawa et al , 2000; Giacco & Brownlee, 2010; Blake & Trounce, 2013).”
Insights into Endothelial Progenitor Cells: Origin, Classification, Potentials, and Prospects
Chopra, H., Hung, M. K., Kwong, D. L., Zhang, C. F., & Pow, E. H. N. (2018) · Stem Cells International · doi:10.1155/2018/9847015 · Cited by 196
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
Toth-Manikowski, S., & Atta, M. G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/697010 · Cited by 192
“This is important because GADPH is inhibited by excess superoxide produced by the electron-transport chain which occurs in the setting of hyperglycemia [29– 31].”
The biology of chronic foot ulcers in persons with diabetes
Gary Sibbald, R., & Woo, K. Y. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.847 · Cited by 198
The Role of Microglia in Diabetic Retinopathy
Grigsby, J. G., Cardona, S. M., Pouw, C. E., Muniz, A., Mendiola, A. S., Tsin, A. T. C., Allen, D. M., & Cardona, A. E. (2014) · Journal of Ophthalmology · doi:10.1155/2014/705783 · Cited by 196
“It is also known that hyperglycemia induced ROS can cause nuclear factor kappa B (NF-κB) translocation to the nucleus [46, 47].”
BackgroundAlderson, N. L., Wang, Y., Blatnik, M., Frizzell, N., Walla, M. D., Lyons, T. J., Alt, N., Carson, J. A., Nagai, R., Thorpe, S. R., et al. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.03.005 · Cited by 202
Oxidative stress, AGE, and atherosclerosis
Schleicher, E., & Friess, U. (2007) · Kidney International · doi:10.1038/sj.ki.5002382 · Cited by 200
Kaneto, H., Nakatani, Y., Kawamori, D., Miyatsuka, T., Matsuoka, T.-A., Matsuhisa, M., & Yamasaki, Y. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.01.004 · Cited by 203
Eckel, R. H., Wassef, M., Chait, A., Sobel, B., Barrett, E., King, G., Lopes-Virella, M., Reusch, J., Ruderman, N., Steiner, G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000013954.65303.c5 · Cited by 199
Antioxidants in the Treatment of Diabetes
Golbidi, S., Alireza Ebadi, S., & Laher, I. (2011) · Current Diabetes Reviews · doi:10.2174/157339911794940729 · Cited by 197
“The production of ROS is reduced by using either an uncoupler of oxidative phosphorylation, over-expression of uncoupling protein-1 or overexpression of MnSOD, such that normalizing the levels of mitochondrial ROS with any of these agents will prevent glucose-induced activation of protein kinase C, formation of advanc…”
BackgroundMitochondrial dysfunction in diabetic tubulopathy
Yao, L., Liang, X., Qiao, Y., Chen, B., Wang, P., & Liu, Z. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155195 · Cited by 186
Cell Death and Diabetic Cardiomyopathy
Cai, L., & Kang, Y. J. (2003) · Cardiovascular Toxicology · doi:10.1385/ct:3:3:219 · Cited by 198
“A cardiac-specific overexpression of IGF-1 has been shown to inhibit myocardial cell death, through suppression of Ang II-mediated ROS and RNS generation, leading to the preservation of cardiac function 30 d after the induction of diabetes (26).”
BackgroundInfluentialUsharani, P., Mateen, A. A., Naidu, M. U. R., Raju, Y. S. N., & Chandra, N. (2008) · Drugs in R & D · doi:10.2165/00126839-200809040-00004 · Cited by 195
Karunakaran, U., & Park, K.-G. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.2.106 · Cited by 197
“The above-mentioned pathways clearly show that hyperglycemia-induced overproduction of superoxide by mitochondria is capable of driving multiple pathways [25].”
BackgroundCai, L., Wang, J., Li, Y., Sun, X., Wang, L., Zhou, Z., & Kang, Y. J. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1829 · Cited by 199
Papakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199
Li, Q., Liao, J., Chen, W., Zhang, K., Li, H., Ma, F., Zhang, H., Han, Q., Guo, J., Li, Y., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.05.024 · Cited by 191
Laybutt, D. R., Kaneto, H., Hasenkamp, W., Grey, S., Jonas, J.-C., Sgroi, D. C., Groff, A., Ferran, C., Bonner-Weir, S., Sharma, A., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.2.413 · Cited by 202
Molecular mechanisms of diabetic vascular complications
Kitada, M., Zhang, Z., Mima, A., & King, G. L. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00018.x · Cited by 193
Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
Qiu, Y.-Y., & Tang, L.-Q. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.004 · Cited by 195
Ozcan, C., Bienengraeber, M., Dzeja, P. P., & Terzic, A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00552.2001 · Cited by 195
“To increase myocardial tolerance and reduce injury, a number of strategies that modulate mitochondrial respiration, ATP production, ion transport and/or free-radical generation have been considered (16, 20, 31, 32, 35, 43).”
BackgroundMolecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome
Bugger, H., & Dale Abel, E. (2008) · Clinical Science · doi:10.1042/cs20070166 · Cited by 198
Intervention against the Maillard reaction in vivo
Monnier, V. M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.014 · Cited by 196
Brocq, M. L., Leslie, S. J., Milliken, P., & Megson, I. L. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.2013 · Cited by 190
“It has been suggested that production of mitochondrial ROS and subsequent oxidative damage during hyperglycemia may be central to much of the pathology of diabetes (46, 319), not least because the function of the mitochondrion itself is particularly susceptible to oxidative damage, and in the pancreatic -cell, it play…”
Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management
Pappachan, J. M., Varughese, G. I., Sriraman, R., & Arunagirinathan, G. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i5.177 · Cited by 190
Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia
Marín, R., Chiarello, D. I., Abad, C., Rojas, D., Toledo, F., & Sobrevia, L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165961 · Cited by 184
Simmons, R. A., Suponitsky-Kroyter, I., & Selak, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505695200 · Cited by 194
Metadata
- Authors
- Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., Giardino, I., & Brownlee, M.
- Affiliations
- Albert Einstein College of Medicine (US)
- The University of Osaka (JP)
- University of Iowa (US)
- Pfizer (United States) (US)
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Brownlee, Michael
- ORCID
- Venue
- Nature
- Published
- 2000-04
- Volume
- 404
- Issue
- 6779
- Pages
- 787-790
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1529592271
- Cited by
- 4,277
- References
- 23
- Citations by year
- 2026: 83 · 2025: 98 · 2024: 97 · 2023: 107 · 2022: 140 · 2021: 151 · 2020: 169 · 2019: 124 · 2018: 141 · 2017: 164 · 2016: 171 · 2015: 200 · 2014: 220 · 2013: 206 · 2012: 242
- FWCI
- 73.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- mitochondrial superoxide, reactive oxygen species, endothelial cells, protein kinase C, advanced glycation end products, sorbitol accumulation, NF-κB activation, UCP1, manganese superoxide dismutase, mitochondrial uncoupling, diabetic vascular complications
- MeSH terms
- Uncoupling Protein 1, Animals, Aspartic Acid, Blood Glucose, Carbonyl Cyanide m-Chlorophenyl Hydrazone, Carrier Proteins, Cattle, Electron Transport, Endothelium, Vascular, Enzyme Activation, Hyperglycemia, Ion Channels, Malates, Membrane Proteins, Mitochondria, Multienzyme Complexes, Oxidoreductases, Protein Kinase C, Rotenone, Sorbitol, Succinate Dehydrogenase, Superoxide Dismutase, Thenoyltrifluoroacetone, Uncoupling Agents, NF-kappa B, Glycation End Products, Advanced, Reactive Oxygen Species, Mitochondrial Proteins, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.